Reactive Biosciences is a discovery platform to discover and develop medicines in innovative and imaginative new ways.
Reactive utilizes the world's foremost boron-based discovery platform to explore inventive and imaginative avenues for medicine discovery and development. Leveraging the distinctive properties of boron, they aim to target unexplored binding sites and advance therapeutics in traditionally deemed undruggable areas. Their objective is to create impactful medicines capable of profoundly altering the trajectory of diseases, positively impacting patients and their families.
Reactive seeks partnerships with companies aiming to expedite transformative medicine discovery and development.